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 ABSTRACT 
 
Herein we investigate the role charged biomaterials and fluid properties have on microfluidic 
capture and isolation of circulating tumor cells.  We determine that heparan sulfate proteoglycans 
on cancer cell surfaces are responsible for elevated electric charge of cancer cells compared with 
white blood cells and that these proteoglycans help mediate adhesive interactions between cells 
and charged surfaces in albumin-containing fluids.  Cancer cell firm adhesion to charged 
surfaces persists when cells are bathed in up to 1% (w/v) human albumin solution, while white 
blood cell adhesion is nearly abrogated.  As many protocols rely on electrical interactions 
between cells and biomaterials, our study could reveal a new determinant of efficient adhesion 
and targeting of specific tissue types in the context of a biological fluid environment.   
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CHAPTER 1 
SURFACTANT FUNCTIONALIZATION INDUCES ROBUST, DIFFERENTIAL 
ADHESION OF TUMOR CELLS AND BLOOD CELLS TO CHARGED NANOTUBE-
COATED BIOMATERIALS UNDER FLOW 
 
1.1 Abstract  
 
The metastatic spread of cancer cells from the primary tumor to distant sites leads to a poor 
prognosis in cancers originating from multiple organs. Increasing evidence has linked selectin-
based adhesion between circulating tumor cells (CTCs) and endothelial cells of the 
microvasculature to metastatic dissemination, in a manner similar to leukocyte adhesion during 
inflammation. Functionalized biomaterial surfaces hold promise as a diagnostic tool to separate 
CTCs and potentially treat metastasis, utilizing antibody and selectin-mediated interactions for 
cell capture under flow. However, capture at high purity levels is challenged by the fact that 
CTCs and leukocytes both possess selectin ligands. Here, a straightforward technique to 
functionalize and alter the charge of naturally occurring halloysite nanotubes using surfactants is 
reported to induce robust, differential adhesion of tumor cells and blood cells to nanotube-coated 
surfaces under flow. Negatively charged sodium dodecanoate-functionalized nanotubes 
simultaneously enhanced tumor cell capture while negating leukocyte adhesion, both in the 
presence and absence of adhesion proteins, and can be utilized to isolate circulating tumor cells 
regardless of biomarker expression. Conversely, diminishing nanotube charge via 
functionalization with decyltrimethylammonium bromide both abolished tumor cell capture 
while promoting leukocyte adhesion. 
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1.2 Introduction 
 Metastasis, the spread of cancer cells from a primary tumor to anatomically distant 
organs, contributes to over 90% of cancer- related deaths [1]. Cancer cells shed from the primary 
tumor, which can number as many as one million cells per gram of tumor per day [2,3], enter the 
bloodstream as circulating tumor cells (CTCs) via the process of intravasation [4,5]. Once in 
blood, CTCs must withstand fluid shear forces and immunological stress to translocate to 
microvessels in anatomically distant organs [6,7]. CTCs adhesively interact with receptors on the 
endothelial cell wall under flow, in a manner similar to the leukocyte adhesion cascade involved 
in inflammation and lymphocyte homing to lymphatic tissues [8,9]. Recent work has shown that 
CTCs display glycosylated ligands similar to leukocytes, which can trigger the initial adhesion 
with selectin receptors on the endothelium [10,11]. Due to their rapid, force-dependent binding 
kinetics, selectins can initiate CTC rolling adhesion along the blood vessel wall [12,13]. CTCs 
transition from rolling to eventual firm adhesion, allowing for transmigration into tissues and the 
formation of secondary tumors [14]. While surgery, radiation, and chemotherapy have proven 
generally successful at treating primary tumors that do not invade the basement membrane, the 
difficulty of detecting distant micrometastases has made the majority of metastatic cancer 
treatments ineffective. As a means to combat metastasis, approaches are currently being explored 
to target and kill CTCs in the bloodstream before the formation of secondary tumors [15-18]. 
Additionally, methods are being developed to isolate CTCs at high purity levels from patient 
blood, for the development of personalized medicine regimens for those with metastatic cancer 
[19-21].  
 CTCs are sparsely distributed in the bloodstream, with CTC concentrations as low as 1-
100 cells/mL [22]. Their separation and isolation from blood is commonly referred to as a 
“needle in a haystack problem”, as leukocytes and erythrocytes are present in concentrations of 
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one million and one billion cells per milliliter of blood, respectively [7,23]. Thus, numerous 
techniques for CTC isolation are in development, including magnetic bead-based CTC separation 
assays [24], flow-based microfluidic platforms for rapid isolation of CTCs from whole blood 
[25,26], and devices to separate tumor cells based on their chemotactic phenotype [27]. Our lab 
has recently developed microscale flow devices that mimic the metastatic adhesion cascade 
process to capture and separate CTCs from whole blood under flow conditions. Utilizing 
surfaces coated with recombinant human E-selectin (ES) and antibodies against the CTC markers 
epithelial cell adhesion molecule (EpCAM) and prostate-specific membrane antigen (PSMA), we 
have fabricated flow devices to rapidly separate viable CTCs from patient blood and deliver 
targeted chemotherapeutics to cancer cells [26,28]. However, improvement of current CTC 
isolation purity levels is challenged by the fact that both CTCs and leukocytes express ES 
ligands [8].  
 Halloysite nanotubes (HNT) are naturally occurring clay minerals that are typically 800 ± 
300 nm in length, 50 ± 70 nm in outer diameter, and 10 ± 30 nm in inner diameter [29]. 
Halloysite (Al2Si2O5(OH)4) is a two-layered (1:1) aluminosilicate that consists of an external 
siloxane (SieOeSi) surface and an internal aluminol (AleOH) surface [30]. At physiological pH, 
HNT has a negatively charged outer surface and a positively charged inner lumen [31], which 
has been exploited for the encapsulation and sustained release of drugs such as Nifedipine, 
Furosemide, and dexamethasone [32]. The differences in HNT surface charge have also been 
exploited for the selective adsorption of anionic and cationic surfactants, which significantly 
alters HNT zeta potential [33]. Our lab has shown that HNT-coated biomaterials of nanoscale 
roughness can increase surface area and thus selectin protein adsorption [34], which can enhance 
selectin-mediated cancer cell capture. Herein, we present the use of HNT in combination with 
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cationic and anionic surfactants to develop nanostructured biomaterials that differentially adhere 
tumor cells and leukocytes under flow conditions.  
 
1.3 Materials and Methods 
1.3.1 Cell culture 
 Human colon adenocarcinoma COLO 205 (ATCC #CCL-222), breast adenocarcinoma 
MCF7 (ATCC #HTB-22), and breast adenocarcinoma MDA-MB-231 (ATCC #HTB-26) cell 
lines were purchased from American Type Culture Collection (ATCC; Manassas, VA, USA). 
COLO 205 and MDA-MB-231 cells were grown in RPMI 1640 supplemented with 10% fetal 
bovine serum (FBS) and 1% PenStrep (PS), all purchased from Invitrogen (Grand Island, NY, 
USA). MCF7 cells were cultured in Eagle's Minimum Essential Medium supplemented with 0.01 
mg/mL bovine insulin, 10% FBS, and 1% PenStrep, all purchased from Invitrogen. Both cell 
lines were incubated under humidified conditions at 37C and 5% CO2, and were not allowed to 
exceed 90% confluence. In preparation for capture assays, cancer cells were removed from 
culture via treatment with Accutase (SigmaeAldrich, St. Louis, MO, USA) for 10 min prior to 
handling. All cells were washed in HBSS, and resuspended at a concentration of 1.0 x 106 
cells/mL in HBSS flow buffer supplemented with 0.5% HSA, 2 mM Ca2+, and 10 mM HEPES 
(Invitrogen), buffered to pH 7.4.  
1.3.2 Polymorphonuclear (PMN) cell isolation 
 Human neutrophils were isolated as described previously [35,36]. Human peripheral 
blood was collected from healthy blood donors via venipuncture after informed consent and 
stored in heparan containing tubes (BD Biosciences, San Jose, CA, USA). Blood was carefully 
layered over 1-StepTM Polymorphs (Accurate Chemical and Scientific Corporation, Westbury, 
NY, USA) and separated via centrifugation using a Marathon 8K centrifuge (Fisher Scientific, 
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Pittsburgh, PA, USA) at 1800 rpm for 50 min. Polymorphonuclear (PMN) cells, also known as 
neutrophils, were extracted and washed in cation-free HBSS, and excess red blood cells were 
lysed hypotonically. Prior to capture assays, neutrophils were resuspended in HBSS flow buffer 
supplemented with 0.5% human serum albumin (HSA), 2 mM Ca2+, and 10 mM HEPES 
(Invitrogen), buffered to pH 7.4.  
1.3.3 Halloysite nanotube functionalization 
 Halloysite nanotubes (HNT; NaturalNano, Rochester, NY, USA) were added to water to 
a final concentration of 6.6% (w/v). 1.6 g HNT was added to 100 mL of 0.1 M aqueous sodium 
dodecanoate (NaL) and 2.4 g HNT were added to 100 mL of 0.1 M aqueous decyl trimethyl 
ammonium bromide (DTAB; SigmaeAldrich) and mixed using a magnetic stirrer for 48 h. 
Surfactant-treated nanotubes were then washed several times in water and allowed to dry 
overnight. Untreated HNT were kept in water at a concentration 6.6% (w/v). NaL and DTAB-
treated HNT were stored in water or methanol respectively, to a final concentration of 6.6% 
(w/v). To evaluate adsorption of surfactants to HNT, the hydrodynamic radius (nm) and zeta 
potential (mV) of HNT, NaL-HNT, and DTAB-HNT were measured by dynamic light scattering 
(DLS) using a Malvern Zetasizer Nano ZS (Malvern Instruments Ltd., Worcestershire, UK). 
Treated and untreated nanotubes at a concentration of 0.37% (w/v) were prepared prior to DLS 
measurements, using the same solvents as described above for functionalized and untreated HNT 
samples. To assess the effect of ES adsorption on HNT zeta potential, 0.5 mL of HNT, NaL-
HNT, and DTAB-HNT at a concentration of 1.1% (w/v) were centrifuged at 13,000 rpm for 10 
min and incubated with 0.5 mL of ES at a concentration of 2.5 mg/mL for 2.5 h at RT. All 
samples were centrifuged at 13,000 rpm for 10 min and resuspended in water at the same 
concentration used for HNT measurements in the absence of ES. Colloidal stability of treated 
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and untreated HNT was assessed by allowing samples of treated and untreated HNT to settle for 
24 h after mixing.  
1.3.4 Fabrication of nanostructured HNT surfaces 
 Microrenathane (MRE) tubing (Braintree Scientific, Braintree, MA, USA) of inner 
diameter 300 mm was cut to 55 cm in length and fastened onto the stage of an Olympus IX-71 
inverted microscope (Olympus, Center Valley, PA, USA). Ethanol was rinsed through the tubes 
using a motorized syringe pump (KDS 230; IITC Life Science, Woodland Hills, CA, USA) at a 
flow rate of 1 mL/min. To functionalize the inner MRE surface with HNT, microtubes were 
washed thoroughly with distilled water, followed by incubation with poly-L-lysine solution 
(0.02% w/v in water) for 5 min and incubation with untreated or NaL-functionalized HNT (NaL-
HNT, 1.1% w/ v) for 5 min. To functionalize the surface with DTAB-treated HNT (DTAB-
HNT), aqueous 2:8 L-glutamic acid (0.1% w/v, Sigma) was incubated in microtubes for 5 min, 
prior to incubation with DTAB-HNT (1.1% w/v) for 5 min. Microtubes were then washed 
thoroughly with distilled water at 0.02 mL/min to remove non-adsorbed halloysite, and cured 
overnight at room temperature (RT). To immobilize ES adhesion protein to HNT-coated 
surfaces, recombinant human ES/Fc chimera (rhE/Fc) (R&D Systems, Minneapolis, MN, USA) 
at a concentration of 2.5 mg/mL was perfused through microtubes at 0.02 mL/min. ES was 
incubated for 2.5 h at RT within HNT-coated microtubes and smooth microtubes in the absence 
of HNT. In some experiments, HNT-coated surfaces were utilized in the absence of ES. All 
surfaces were blocked for nonspecific cell adhesion for 1 h via perfusion and incubation with 5% 
(w/v) bovine serum albumin (BSA, SigmaeAldrich) at 0.02 mL/ min. ES protein was activated 
with calcium enriched flow buffer for 5 min prior to cell capture experiments.  
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1.3.5 ES surface adsorption assay 
 To characterize ES adsorption on smooth and immobilized HNT surfaces, anti- human 
CD62E (BD Biosciences, San Jose, California, USA) conjugated to an allophycocyanin (APC) 
fluorophore was perfused through microtubes at 0.02 mL/min and incubated for 2.5 h at RT, 
following incubation with ES protein and BSA as described above. Unbound ES antibodies were 
washed from surfaces using flow buffer. Fluorescent images of adsorbed ES on surfaces were 
acquired at 90 magnification using an IX-81 inverted microscope linked to a Hitachi CCD 
camera (Hitachi, Japan). Fluorescent images were analyzed using a three dimensional (3D) 
surface plot plug-in for ImageJ to obtain pixel intensity data.  
1.3.6 HNT surface characterization  
 To characterize immobilized HNT surfaces, 100 mL of 1.1% untreated HNT, NaL- HNT, 
and DTAB-HNT solutions were carefully dried on 3 cm x 3 cm polyurethane (PU) sheets 
(Thermo Scientific, USA) and sputter coated with Au prior to visualization. SEM images of 
untreated HNT, NaL-HNT, and DTAB-HNT immobilized onto PU surfaces were acquired with 
the Leica Stereoscan 440 scanning electron microscope (Leica Microsystems Gmbh, Wetzlar, 
Germany). For atomic force microscopy (AFM) measurements, flat samples of HNT-coated 
surfaces were prepared on polystyrene microscope slides (Thermo Fisher Scientific, Rochester, 
NY, USA) using an 8-well flexiPERM gasket (SigmaeAldrich) following the same method used 
for microtube functionalization. Samples were then imaged using a Veeco DI-3000 AFM (Veeco 
Instruments, Inc., Woodbury, NY). 10 mm x 10 mm images were recorded at random locations 
on each sample. Three images each of the flat HNT-coated samples and untreated surfaces were 
analyzed in WSxM 5.0 software [37] to inspect the surface height profiles and root-mean-square 
surface roughness.  
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1.3.7 Cell capture assay 
 Cell suspensions were perfused through microtubes using a motorized syringe pump and 
monitored via an inverted microscope linked to a Hitachi CCD KP-M1AN camera (Hitachi, 
Japan) and a Sony DVD Recorder DVO-1000MD (Sony Electronics Inc., San Diego, California, 
USA). Cancer cells were perfused at 0.008 mL/min (wall shear stress of 0.5 dyn/cm2) for 15 min, 
and then 0.04 mL/min (wall shear stress of 2.5 dyn/cm2) for 45 min. Polymorphonuclear 
neutrophils were perfused through microtubes at 0.04 mL/min for 60 min. Mixtures of cancer 
cells and leukocytes at cancer cell:leukocyte ratios of 1:1 and 1:10 were perfused through 
microtubes at 0.04 mL/min for 60 min. The number of adhered cells was taken from ten random 
video frames for each microtube.  
1.3.8 Statistical analysis 
 Data sets were plotted and analyzed using Microsoft Excel (Microsoft, Redmond, WA, 
USA) and GraphPad Prism 5.0 (GraphPad software, San Diego, CA, USA). All results were 
reported as the mean ± standard error of the mean (SEM) or standard deviation (SD) as 
indicated. Two-tailed paired and unpaired t-tests, and one-way ANOVA with Tukey post-tests 
were utilized for statistical analyses. P-values less than 0.05 were considered significant.  
1.4 Results 
 We are interested in exploiting the negatively charged outer surface and positively 
charged inner lumen of HNT to alter surface charge via simple surfactant functionalization (Fig. 
1A), while maintaining HNT surfaces of nanoscale roughness, to differentially capture cancer 
cells and blood cells via ES adhesion proteins under flow conditions (Fig. 1B). Due to the 
negatively charged outer surface and positively charged inner lumen of HNT, we sought to 
manipulate the nanotube charge using both positive and negatively charged surfactants (Fig. 1A). 
Sodium dodecanoate (NaL) and decyl trimethyl ammonium bromide (DTAB) were used to 
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neutralize the positive inner lumen and the negative outer surface charge, respectively (Fig. 1A). 
NaL and DTAB possess negative and positive functional head groups, respectively, which are 
needed to bind to the surface and inner lumen of HNT [33]. The aqueous dispersibility of HNT is 
affected by both hydrophobic interactions and electrostatic effects [33]. Functionalization of 
HNT by mixing with NaL (NaL-HNT) for 48 h formed stable aqueous dispersions (Fig. 1C), and 
possessed a negative zeta potential greater than that of untreated HNT (Fig. 1D). These results 
are consistent with the idea that NaL molecules penetrate within HNT and neutralize the positive 
charge within the nanotube lumen. Additionally, the increase in negative nanotube charge due to 
NaL treatment allows the nanotubes to interact with water via charge-dipole interactions. 
Conversely, functionalization of HNT with DTAB (DTAB-HNT) via mixing for 48 h 
diminished the intrinsic negative charge of HNT (Fig. 1D), with polar head groups of DTAB 
neutralizing external negative charges. At the same time, the long hydrocarbon chain of DTAB is 
left exposed to solvent water molecules. For DTAB-HNT to disperse in water, non-polar chains 
must move between water molecules, substituting their weak attractions for strong hydrogen 
bonds among water molecules [38]. Unable to substitute for intermolecular hydrogen bonds, and 
aggregating due to hydrophobic forces, DTAB-HNT quickly sediment in a manner similar to 
untreated HNT (Fig. 1C). Adsorption of ES adhesion receptors to HNT, NaL-HNT, and DTAB-
HNT altered charge minimally, by ~2-5 mV (Fig. 1D).  
Functionalized HNT can then be immobilized in polyurethane microtubes to create HNT-
coated surfaces of nanoscale roughness (Fig. 1B). To evaluate the effect of surfactant treatment 
on the immobilization of HNT to form surfaces of nanoscale roughness, we characterized both 
treated and untreated HNT samples immobilized on polyurethane sheets using scanning electron 
microscopy (SEM). Larger polyurethane sheets were used for analysis rather than microtubes to 
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minimize sample damage during handling and preparation. Poly-L-lysine (PLL) coatings were 
used to immobilize HNT and NaL-HNT, with the negatively-charged HNT and NaL-HNT being 
attracted to the positively-charged PLL coating via electro- static interactions. Conversely, 
negatively-charged glutamic acid coatings were used to immobilize DTAB-HNT. SEM images 
revealed that, regardless of surfactant treatment, HNT immobilization creates filamentous 
surfaces, with HNT protruding from all surfaces (Fig. 1E). AFM images also confirmed that 
immobilized HNT samples all displayed tubular structures protruding outward from the surfaces 
at varying feature heights, regardless of surfactant treatment (Fig. 1F, G). Root mean square 
(RMS) roughness values of all HNT-coated surfaces were within the range of 140-200 nm (Fig. 
1H). This range of roughness has previously been shown to enhance cancer cell adhesion via 
increasing formation of focal adhesion complexes [39]. These data suggest that simple surfactant 
mixing can functionalize and alter HNT charge, without effecting the immobilization of HNT to 
create surfaces of nanoscale roughness. 
To evaluate the effects of functionalized HNT surfaces (Fig. 2A) on the adsorption of ES 
receptors, ES was immobilized on smooth, untreated, and treated HNT surfaces and labeled with 
fluorescent ES antibodies to determine protein fluorescence intensity. Fluorescence micrographs 
indicated that ES was immobilized on smooth (Fig. 2B), NaL-HNT (Fig. 2C), 
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Fig. 1. Functionalization of halloysite nanotubes (HNTs) with surfactants to fabricate 
nanostructured surfaces of altered surface charge for flow-based cell capture assays. (A) 
Negative charge of HNT is enhanced via mixing and functionalization with sodium 
dodecanoate (NaL) surfactant (NaL-HNT). Intrinsic negative charge of HNT is attenuated 
via hmixing and functionalization of decyltrimethylammonium bromide (DTAB) surfactant 
(DTAB-HNT). (B) HNTs are immobilized onto polyurethane flow device surfaces coated 
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with poly-L-lysine (for HNT and NaL-HNT) or glutamic acid (for DTAB-HNT) for cell 
capture assays. Surfaces can be further functionalized with adhesion proteins, such as E-
selectin (ES) to facilitate cell capture. (C) Stability of HNT, NaL-HNT, and DTAB-HNT 
dispersions (1.1 wt %) 24 h after mixing. (D) Zeta potential (mV) measurements of HNT 
samples, incubated with and without E-selectin (ES), using dynamic light scattering. Data 
are presented as the mean ± standard deviation of three independent measurements. (E) 
SEM images of polyurethane substrates with immobilized HNT samples. Scale bar = 2 μm. 
(F) AFM images of HNT samples immobilized on polyurethane substrates. Scale bar = 2 
m. (G) Representative surface feature height profiles of HNT samples immobilized onto 
polyurethane substrates, compared to smooth surfaces. Nanotube profiles have been shifted 
up by 100 nm for ease of viewing. (H) Root-mean-square (RMS) roughness measurements 
of HNT surfaces. Data are mean ± standard deviation of three independent measurements. 
 
untreated HNT (Fig. 2D), and DTAB-HNT (Fig. 2E). Quantification of surface fluorescence 
intensity showed that untreated and treated HNT surfaces increased ES adsorption, with all HNT 
surfaces possessing significantly greater average ES fluorescence intensities than smooth 
surfaces (Fig. 2F). Enhanced ES adsorption to HNT surfaces is likely due to the increase in 
surface area created by HNT immobilization, previously shown by our lab to increase protein 
adsorption [34]. Differences in ES adsorption on treated and untreated HNT could be due to 
changes in HNT surface charge, since differences in surface roughness were minimal (Fig. 1H) 
and thus surface area differences between HNT surfaces are likely negligible. With an isoelectric 
point at pH 5.2, ES assumes a net negative charge at physiologic pH. Decreased ES adsorption 
on NaL-HNT compared to other HNT surfaces is thus likely due to electrostatic repulsion 
between ES and NaL-HNT, both negatively charged. These results indicate that HNT 
immobilization to biomaterial surfaces enhances ES adsorption. 
We then investigated the use of nanostructured surfaces of negatively charged NaL-HNT 
to facilitate capture of flowing tumor cells and leukocytes via ES-mediated adhesion. Our lab has 
previously developed reactive biomaterial surfaces that have been utilized for the study of 
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Fig. 2. Detection of immobilized fluorescent ES on biomaterial surfaces. (A-E) 
Representative high magnification fluorescence micrographs of recombinant human ES 
(red) adsorbed on immobilized HNT (control without ES; A) surfaces, smooth (ES only; B) 
surfaces, immobilized NaL-HNT (C), HNT (D), and DTAB-HNT (E) coated biomaterial 
surfaces. Scale bar =  40 µm. (F) Immobilized ES relative fluorescence intensity values on 
smooth and nanostructured biomaterial surfaces. Calculated values are mean ± standard 
deviation (n =  3). Statistics were calculated using a one-way ANOVA with Tukey post test. 
***P < 0.0001. (For interpretation of the references to color in this figure legend, the 
reader is referred to the web version of this article.) 
 
leukocyte, stem cell, and tumor cell adhesive interactions with selectins under flow [13,40,41]. 
Colorectal adenocarcinoma COLO 205 and breast adenocarcinoma MCF7 cells were used in 
these experiments as model CTCs because they possess ligands for ES, are known to interact 
with ES under physiological shear stresses [42,43], and form metastases in vivo [44-46]. As 
expected, COLO 205 cells adhesively interacted with nanostructured HNT surfaces consisting of 
immobilized ES (ES þ HNT) under flow (Fig. 3A), at a physiological flow rate of 0.04 mL/min 
(wall shear stress (WSS) = 2.5 dyn/cm2). Interestingly, increasing the negative charge of HNT 
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with NaL surfactant dramatically increased the number of COLO 205 cells recruited via ES 
under flow (Fig. 3A), compared to untreated HNT-coated surfaces. Enhancement of HNT charge 
with NaL increased the number of COLO 205 cancer cells captured from flow by ~150%, 
compared to surfaces comprised of HNT without surfactant treatment (Fig. 3B). Capture of 
breast MCF7 cancer cells from flow on NaL- HNT surfaces increased by over 800% compared 
to HNT surfaces without surfactant treatment, demonstrating that this approach can be utilized to 
target and capture tumor cells from multiple organs (Fig. 3C). 
  
Fig. 3. Negatively charged surfactant-functionalized HNT simultaneously enhance cancer 
cell capture while eliminating leukocyte adhesion. (A) E-selectin (ES)-mediated adhesion of 
colorectal adenocarcinoma COLO 205 cells under flow over surfaces coated with ES + 
HNT and ES + NaL-HNT. Yellow arrows denote adhered COLO 205 cells. Scale bar = 100 
µm. (B, C) Number of captured COLO 205 (B) and breast adenocarcinoma MCF7 (C) cells 
per 180,000 µm2. n = 20 or more image frames analyzed for each condition. Statistics 
calculated using a two-tailed unpaired t-test. ***P < 0.0001. (D) ES-mediated adhesion of 
primary human leukocytes under flow over surfaces coated with ES + HNT and ES + NaL-
HNT. Orange arrows denote adhered neutrophils. Scale bar = 50 µm. (E) Number of 
captured leukocytes per 180,000 µm2. Calculated values are mean ± SEM. n = 20 or more 
image frames analyzed for each condition. Statistics calculated using a two-tailed unpaired 
t-test. ***P < 0.0001. (F) Purity (%) of COLO 205 cancer cells captured from a mixture of 
cancer cells and leukocytes at COLO 205:leukocyte ratios of 1:1 and 1:10. (For 
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interpretation of the references to color in this figure legend, the reader is referred to the 
web version of this article.) 
 
Approximately 1 CTC is present for every one million leukocytes in a given patient blood 
sample, and CTCs and leukocytes both possess similar ligands for ES. However, enhancement of 
HNT charge with NaL had the opposite effect on leukocyte adhesion to ES. While flowing 
leukocytes readily adhered to surfaces consisting of ES and HNT in the absence of surfactant 
(flow rate = 0.04 mL/ min, WSS 1⁄4 2.5 dyn/cm2), nearly all adhesion was abolished upon 
enhancing HNT charge with NaL (Fig. 3D). The number of flowing leukocytes captured from 
flow decreased by over 90% on NaL-HNT surfaces, compared to surfaces consisting of HNT 
without surfac- tant treatment (Fig. 3E). We then performed an initial assessment of the purity of 
flowing cancer cells captured from a mixture of both COLO 205 cancer cells and leukocytes 
(flow rate = 0.04 mL/min, WSS = 2.5 dyn/cm2), with COLO 205:leukocyte ratios of 1:1 and 
1:10. Purities as high as 90% and 75%, or enrichments as high as four- and twenty-fold, were 
achieved upon perfusion of cell mix- tures of 1:1 and 1:10, respectively, over HNT surfaces with 
enhanced negative charge (Fig. 3F). Overall, these data suggest that alteration of HNT charge 
with NaL can induce a robust response to both enhance cancer cell capture and diminish 
leukocyte adhesion, both in isolation and in mixtures of cancer cells and leukocytes of varying 
ratios. 
To assess if ES-mediated cancer cell capture and leukocyte repulsion on nanostructured 
surfaces is dependent on HNT charge, we functionalized HNT with DTAB surfactant to abolish 
the intrinsic negative charge of HNT (Fig. 1A, D). Upon perfusion of COLO 205 cells at  
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Fig. 4. HNT treatment with cationic surfactant reverses tumor cell and leukocyte capture 
on nanostructured biomaterial surfaces. Cancer cell and leukocyte capture on nano- 
structured surfaces under flow is dependent on HNT charge. (A) Negating HNT charge 
using DTAB surfactant abolishes cancer cell capture under flow. Yellow arrows denote 
adhered COLO 205 cells. Scale bar =  200 µm. (B, C) Number of captured COLO 205 (B) 
and MCF7 (C) cells per 180,000 µm2. n =  20 or more image frames analyzed for each 
condition. Statistics calculated using a two-tailed unpaired t-test. ***P < 0.0001. (D) 
Negating HNT charge using DTAB surfactant restores leukocyte capture under flow. 
Orange arrows denote adhered leukocytes. Scale bar =  200 µm. (E) Number of captured 
leukocytes per 180,000 µm2. Calculated values are mean ± SEM. N =  20 or more frames 
analyzed for captured cells for each condition. Statistics calculated using a two-tailed 
unpaired t-test. ***P < 0.0001. (F) Comparison of ES-mediated adhesion of leukocytes and 
COLO 205 cells per 180,000 µm2 as a function of HNT zeta potential. Error bars denote 
standard error of the mean. Statistics were calculated using a two-tailed unpaired t-test. n 
= 30 or more image frames analyzed. ***P < 0.0001. (For interpretation of the references to 
color in this figure legend, the reader is referred to the web version of this article.) 
 
physiological flow rates (flow rate = 0.04 mL/min, WSS = 2.5 dyn/cm2) over surfaces consisting 
of ES + DTAB-HNT, it was evident that cancer cells interacted minimally with surfaces of 
diminished charge (Fig. 4A). The number of colon and breast cancer cells captured on DTAB-
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HNT surfaces of minimal charge was reduced by >99% and >97%, respectively, compared to 
NaL-HNT surfaces of higher negative charge (Fig. 4B, C). Leukocyte adhesion under flow, 
absent on HNT surfaces of higher negative charge, was enhanced on ES + DTAB-HNT of 
diminished charge (Fig. 4D). Dampening of negative HNT charge increased the capture of free- 
flowing leukocytes by 60-fold, compared to ES + NaL-HNT surfaces of higher negative charge 
(Fig. 4E). Plotting the number of adherent cancer cells and leukocytes as a function of HNT zeta 
potential shows that HNT of higher negative charge can enhance cancer cell adhesion while 
minimizing leukocyte adhesion, and this adhesion response can be reversed by reducing the 
negative charge of HNT (Fig. 4F). Taken together, these results suggest that differential ES-
mediated adhesion of cancer cells and leukocytes is dependent on surfactant functionalization 
and charge alteration of HNT. 
To assess if HNT charge can directly mediate cell interactions, the effects of surfaces 
consisting of charged HNT, both in the presence and absence of ES, on cancer cell firm adhesion 
were examined. Few COLO 205 cancer cells firmly adhered to untreated HNT in the absence of 
ES (Fig. 5A), while the addition of ES allowed for successful recruitment and firm adhesion of 
cancer cells. Interestingly, surfaces consisting of highly negatively charged NaL-HNT alone, 
without ES immobilization, induced a significant in- crease in COLO 205 firm adhesion, 
compared to untreated HNT with immobilized ES. ES immobilization on NaL-HNT significantly 
increased COLO 205 cell firm adhesion, indicating that ES remains functional on NaL-HNT 
surfaces. However, given that ES only increased firm adhesion to NaL-HNT by ~15% compared 
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Fig. 5. NaL-HNT surfaces capture tumor cells in the absence of ES. (A) Firm adhesion of 
colorectal adenocarcinoma COLO 205 cells per 180,000 µm2 to HNT and NaL-HNT in the 
presence and absence of the E-selectin (ES) adhesion receptor. Statistics were calculated 
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using a one-way ANOVA with Tukey post test. ***P < 0.0001. *P < 0.01. (B-E) Comparison 
of triple-negative breast cancer MDA-MB-231 cell capture on HNT sur- faces under flow, 
in presence and absence of ES adhesion proteins. Red arrows denote adhered MDA-MB-
231 cells. Scale bar = 100 µm. (F) Captured MDA-MB-231 cells per 180,000 µm2 to HNT 
surfaces in the presence and absence of the ES adhesion protein. Statistics calculated using 
a one-way ANOVA with Tukey post test. ***P < 0.0001. NS: not significant. (For 
interpretation of the references to color in this figure legend, the reader is referred to the 
web version of this article). 
 
to NaL-HNT alone, it appears that surfactant immobilization plays a role in recruitment of tumor 
cells from flow. These results indicate that HNT charge affects the adhesion of COLO 205 
cancer cells to surfaces consisting of negatively charged NaL-HNT. 
In an effort to exploit adhesion of tumor cells in the absence of specific adhesion ligands, 
the adhesion of the metastatic MDA-MB- 231 breast cancer cell line to HNT-coated surfaces was 
examined. The MDA-MB-231 cell line is known as a “triple-negative” breast cancer (TNBC) 
cell type. Due to its lack of estrogen receptor, progesterone receptor, and human epidermal 
growth factor receptor 2 (HER2) expression, limited progress has been made in terms of 
therapeutic regimens for TNBC, and patients with the disease typically have the worst outcomes 
[47]. Additionally, MDA-MB-231 cancer cells have little to no ES ligand expression under 
normal culture conditions, and have been shown to engage in little to no interaction with ES and 
endothelial cells under flow [48,49]. Similar results were obtained in this study, as minimal 
MDA-MB-231 cells were found to adhesively interact with ES on HNT-coated surfaces, along 
with surfaces coated with untreated HNT alone (Fig. 5B, C, F). However, negatively charged 
NaL-HNT greatly enhanced the recruitment of MDA-MB-231 cells to the surface, both in the 
presence and absence of ES (Fig. 5D-F). NaL-HNT induced significant increases in the number 
of MDA-MB-231 cells captured from flow regardless of adhesion protein immobilization (Fig. 
5F). These results suggest that NaL-HNT surfaces can be utilized to capture CTCs regardless of 
adhesion receptor expression. While immobilization of the ES adhesion receptor can enhance the 
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capture of cancer cells that express ES ligands, negatively charged NaL-HNT can be utilized to 
capture CTCs that do not express typical biomarkers or adhesion receptors. 
1.5 Discussion 
As cells approach a charged surface, the cell membrane can be either deformed toward 
the surface or away from it, depending on the charges present [50]. For cells expressing ES 
ligands, membrane deformation near charged surfaces could affect the number of cell ligands 
interacting with ES, and thus affect capture under flow conditions. Leukocytes have previously 
been reported to possess a negatively charged membrane potential [51]. Through coulombic 
interactions, leukocytes can be recruited to DTAB-HNT surfaces thereby enhancing ES ligation, 
while NaL-HNT repels leukocytes from approaching within a reactive distance to ES (Fig. 3F). 
Thus, it is logical that leukocytes with a high negative charge can be pre- vented from interacting 
with adhesion receptors on surfaces con- sisting of negatively charged HNT. What remains to be 
seen is how CTC capture is enhanced on surfaces consisting of HNT of high negative charge. 
Few studies have examined the zeta potential of cancer cells, and have generally found that zeta 
potential is less negative than that of leukocytes [52,53]. The answer to enhanced cancer cell 
capture on NaL-HNT could lie in the CTC glycocalyx, a gel-like layer of biologically inert 
macromolecules on the CTC surface that can extend as far as 500 nm from the CTC surface [54]. 
In particular, the synthesis of glycocalyx components can be impaired during malignant 
transformation, causing cancer cells to greatly over- express the glycocalyx component 
hyaluronan on their surface [55,56]. Additionally, leukocytes do not present a similar thick 
glycocalyx on surface. Thus, it is possible that components of the glycocalyx interact with NaL-
HNT via electrostatic interactions, or potentially act as an adhesion ligand to the NaL surfactant. 
Future studies evaluating the surface charge of CTCs, and the effect of glycocalyx coatings could 
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shed further light on the mechanisms contributing to enhanced cancer cell adhesion to charged 
nanostructures. 
1.6 Conclusion 
The present study demonstrates, for the first time, that simple surfactant functionalization 
can induce a robust, differential adhesion response of tumor cells and blood cells on nanotube- 
coated surfaces. Surfaces consisting of differentially charged HNT can be fabricated without 
significant alteration in nanostructure. Functionalization of HNT with NaL was utilized to 
enhance the negative charge of HNT, which resulted in a significant increase in ES-mediated 
cancer cell adhesion while simultaneously repelling leukocyte adhesion. In the absence of ES, 
NaL-HNT surfaces suc- cessfully captured metastatic cells that do not express the adhesion 
receptor. Conversely, diminishing HNT charge with DTAB reversed the response, abolishing 
cancer cell adhesion while promoting leukocyte adhesion to ES. This straightforward method to 
functionalize HNT with surfactants not only shows that capture of tumor cells and blood cells is 
dependent on HNT charge, but also provides a unique platform to isolate CTCs, from patient 
blood for the development of personalized medicine regimens. 
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Chapter 2 
Exploiting Serum Interactions with Cationic Biomaterials Enables Label-Free Circulating 
Tumor Cell Isolation 
 
2.1 Abstract 
Mounting evidence has shown that, in biological fluids, proteins adsorbed to the surfaces of 
nanomaterials that are known as protein corona can critically affect the interactions of the 
nanomaterials with living cells. Little is known, however, about how abundant free proteins in 
biological systems can influence such physical interactions. By using a model 
systems−microscale flow device, we demonstrate for the first time that free serum proteins can 
greatly modulate electric charge interactions between materials and cells (white blood cells and 
cancer cells) through enhanced fluid dielectric. We found that such an effect was independent of 
protein fouling. We show further that living cells (cancer cells and white blood cells) with 
surface charges ranging from -8mV through -22mV present significantly varying interactions 
with positively charged surfaces only in the presence of free proteins. Moreover, when 
microparticles with surface charge matched to that of cells interact with positively charged 
materials, the observed difference is found to depend solely on the surface charge of cells 
irrespective of the origin of those cells. Lastly, we observed that the level of heparan sulfate 
proteoglycans on a cell surface correlates with cell charge and thus contributes to differential 
interactions between cells and positively charged surfaces. Insofar as many gene delivery and 
cell isolation platforms rely on electrical interactions between living cells and materials, our 
study could reveal a new determinant of efficient adhesion and targeting in the context of a 
biological-fluid environment.2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                 
2 The content of this chapter was presented at a conference: 
Carlos A. Castellanos*, Michael J. Mitchell*, Michael R. King, “Exploiting Serum Interactions with Cationic 
Biomaterials Enables Label-Free Circulating Tumor Cell Isolation” 
*Authors contributed equally to this work. 
C.A.C, M.J.M., and M.R.K. conceived of research; C.A.C., M.J.M., and M.R.K. designed research; C.A.C. and 
M.J.M. performed research; M.J.M. and C.A.C. analyzed data; M.J.M., C.A.C., and M.R.K. wrote the paper. 
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2.2 Introduction 
By definition biomaterials interface with biological systems, including bodily fluids and a 
variety of cell types [1-3]. They have gained overwhelming popularity due to the wide range of 
applications for which they are suitable in diagnostic devices [4-5], implantations, and drug 
delivery [6-10]. Meanwhile, they remain under intensive study, as the ultimate goal of 
biomaterials is biocompatibility in material–host interaction, cytotoxicity, degradation, and so on 
[11-12]. For certain medical applications, biomaterials are designed to support cell adhesion in 
stem cell implantation or the introduction of large molecules into cells in the delivery of nucleic 
acids or antigens [13-16]. Current schemes for facilitating material–cell interaction generally fall 
into two categories. The first type involves using bio-specific molecules to achieve targeted 
specificity including antibodies, peptides, and aptamers [17-19]. In the other scheme, 
electrostatic interactions, especially those with cationic materials, have been widely used in 
regenerative medicine for the following reasons: (1) They are relatively inexpensive compared 
with biomolecules, particularly when the materials need to be scaled up; (2) nearly all types of 
cells (including bacteria and mammalian cells) are negatively charged on the surface so that 
cationic materials can potentially target universal cell types when specificity is unnecessary [20-
23]; and (3) their ability to be easily modified makes them attractive for many biological 
applications [24]. As a result, there has been a vast amount of research focusing on designing 
novel natural or synthetic cationic polymers with specific biological functionality. For example, 
poly (L-lysine) (PLL) and polyethylenimine (PEI) are considered efficient nucleic acid-
condensing agents in non-viral gene delivery systems [25].  
However, owing to surface charge and structure, biomaterials—including cationic 
polymers—are capable of adsorbing biomolecules upon contact with biological systems [26-27]. 
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In particular, over the past few years several investigations have shown that proteins can bind to 
the surface of nanomaterials commonly known as protein corona in the context of biological 
fluids such as serum [28]. Importantly, the formation of such a protein layer can alter the 
biological identity of the nanomaterials and therefore affect biomedical applications. Moreover, 
cationic materials are found to have elevated adsorption of proteins compared with neutral 
polymers [29-30]. Despite extensive studies on immobilized protein corona, no study has been 
carried out to examine how free proteins in biological fluid can modulate electric charge 
interactions between biomaterials and cells in light of broad interest in utilizing cationic 
materials for biomedical applications. 
Since cationic biomaterials commonly interface with cells in the presence of biological 
fluids containing a large amount of proteins, we reasoned that such free proteins can modulate 
fluid dielectric and thereby affect interactions between charged objects, as suggested by 
Coulomb's Law. We measured the surface charge of cells of varying origins and found that the 
cells present a broad range of negative charge, from -8mV to -22mV. Moreover, the cells 
interacted with cationic materials differently (from no interaction to moderate or strong 
adhesion) depending on their specific surface charge in the presence of buffered saline 
containing albumin, the most abundant protein in the serum. 
2.3 Materials and Methods 
2.3.1 Cell Culture 
Human breast adenocarcinoma cell line MDA-MB-231 (ATCC #HTB-26), lung 
carcinoma cell line A549 (ATCC #CCL-185) and colorectal carcinoma cell line HCT-116 
(ATCC #CCL-247) were purchased from American Type Culture Collection (ATCC; Manassas, 
VA, USA). MDA-MB-231 cells were grown in DMEM supplemented with 10% fetal bovine 
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serum (FBS) and 1% PenStrep (PS), all purchased from Invitrogen (Grand Island, NY, USA). 
A549 and HCT-116 cells were cultured in RPMI 1640 supplemented with 10% FBS, and 1% 
PenStrep, all purchased from Invitrogen. All cell lines were incubated under humidified 
conditions at 37° C and 5% CO2, and not allowed to exceed 90% confluence. In preparation for 
capture assays, cancer cells were removed from culture via treatment with enzyme free cell 
dissociation buffer (ThermoFisher) for 30 min prior to handling. Cells were washed in PBS, and 
resuspended at a concentration of 5.0 x 105 cells/mL in PBS flow buffer supplemented with 0 - 
1% human serum albumin, 2 mM Ca2+, and 10 mM HEPES (Invitrogen), buffered to pH 7.4. 
2.3.2 Mononuclear Leukocyte Isolation 
 Human leukocytes were isolated as described previously. Briefly, human peripheral 
blood was collected from healthy blood donors via venipuncture after informed consent and 
stored in heparin containing tubes (BD Biosciences, San Jose, CA, USA). Blood was carefully 
layered over Ficoll-Paque (GE Healthcare Life Sciences) and separated via centrifugation using a 
Marathon 8K centrifuge (Fisher Scientific, Pittsburgh, PA, USA) at 2400 rpm for 15 min. 
Mononuclear leukoctyes were extracted and washed in cation-free HBSS, and excess red blood 
cells were lysed hypotonically. Prior to capture assays, leukocytes were resuspended in PBS flow 
buffer supplemented with 0-1% human serum albumin (HSA), 2mM Ca2+, and 10 mM HEPES 
(Invitrogen), buffered to pH 7.4. 
2.3.3 Fabrication of Polymer-Coated Surfaces 
 Microrenathane (MRE) tubing (Braintree Scientific, Braintree, MA, USA) of inner 
diameter 300 μm was cut to 55 cm in length and fastened onto the stage of an Olympus IX-71 
inverted microscope (Olympus, Center Valley, PA, USA). To functionalize the inner MRE 
surface with cationic polymer, microtubes were washed thoroughly with distilled water, followed 
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by incubation with aqueous 0.025 – 0.1% poly-L-lysine, polyethyleneimine, or poly(allyl)amine 
for 30 min. Microtubes were then washed thoroughly with distilled water to remove nonadsorbed 
polymer, and used immediately for cell capture assays. 
2.3.4 Cell Capture Assays 
Cell suspensions were perfused through microtubes using a motorized syringe pump 
(KDS 230; IITC Life Science, Woodland Hills, CA, USA)  and monitored via an inverted 
microscope linked to a Hitachi CCD KP-M1AN camera (Hitachi, Japan) and a Sony DVD 
Recorder DVO-1000MD (Sony Electronics Inc., San Diego, California, USA). All cells and 
particles were perfused at 0.008 mL/min (wall shear stress of 0.5 dyn/cm2) for 10 min, and then 
0.008 mL/min for another 10 min to remove un-adhered cells. The number of adhered cells was 
taken from up to 30 random video frames for each microtube. “Firmly adhered cells” denote 
cells that were captured from flow. 
2.3.5 Cell Electric Charge Characterization 
To evaluate the electric charge of cells, zeta potential (mV) of all cell samples treated and 
un-treated with Bacteroides Heparanase III (New England BioLabs Inc.) were measured by 
dynamic light scattering (DLS) using a Malvern Zetasizer Nano ZS (Malvern Instruments Ltd., 
Worcestershire, UK). To assess expression of heparan sulfate proteoglycans on cell surfaces, 
Anti-Heparan Sulfate Proteoglycan 2 antibody [A74] (ab23418) was added to cell suspension 
and adherent antibody determined using flow cytometry.  
 
2.3.6 Fluid Dielectric Measurements 
Fluid dielectric constant was measured using a Novocontrol Broadband Dielectric 
Spectrometer (Montabaur/ Germany) at 100 Hz frequency.  Air was used to simulate vacuum 
  
34 
capacitance. Measured capacitance of water and aqueous albumin solutions used to determine 
dielectric constants by dividing measured values with the capacitance of air. 
2.3.7 Immunofluorescence Preparation of CTCs Isolated from Cancer Patient Blood 
Following processing with PLL-coated devices, captured cells were released from the 
microtube and plated onto 8 mm, #1.5 thickness coverslips (Electron Microscopy Services, 
Hatfields, PA, USA) coated with 1% Cell-Tak (Corning). Cells were fixed with 2% 
formaldehyde in 50% Phem buffer (60 mM PIPES, 25 mM HEPES, 10 mM EGTA, 2 mM 
MgCl2) and blocked overnight in 10% Normal Goat Serum (Jackson ImmunoResearch, PA, 
USA) and 6% Bovine Serum Albumin in DPBS (Corning). Cells were then processed for 
immunofluorescence labeling. The following antibodies were used: mouse monoclonal anti-
CD45 directly conjugated with QDot 800 (Invitrogen, Carlsbad, CA), mouse monoclonal anti-
EpCAM directly conjugated with Alexa Fluor 647 (Biolegend), mouse monoclonal anti-PSMA 
(J591) directly conjugated with fluorescein isothiocyanate (FITC, provided by Dr. Neil Bander, 
Weill Cornell Medical College, NY, USA). Cells were then permeabilized with 0.25% Triton X-
100 (Sigma) and stained with mouse monoclonal anti pan-cytokeratin (Biolegend) directly 
conjugated with CF594 (Biotium). DNA was stained with 1 µg mL-1 4’,6-diamidino-2-
phenylindole (DAPI; Sigma). The cells were mounted using Mowiol. 
 
2.3.8 CTC Identification and Downstream High Resolution Confocal Microscopy 
Low resolution, multiplex tile scanning of the coverslips was performed using a 10x 
objective (Zeiss, Germany). Reconstructed tile scans of coverslips were subjected to an 
algorithm to identify putative CTCs based on size and shape, DAPI positivity, cytokeratin 
positivity, and CD45 negativity. Individual positions of CTCs are marked and rank-ordered by 
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descending CK staining intensity and subjected to high resolution imaging. Putative CTCs were 
imaged at high resolution with 20-50 individual z-slices at 0.24 um per z-plane recorded for each 
cell. Images were acquired using Yokogawa CSU-X1 confocal microscope with a 63x/1.4NA 
objective (Zeiss). Three-dimensional image reconstruction was performed and manually 
reviewed in order to eliminate false positive CTCs. CTCs were confirmed on basis of DAPI, 
cytokeratin, and CD45 staining. Only confirmed CTCs were included in final enumeration. 
2.3.9 Statistical Analysis 
Data sets were plotted and analyzed using Microsoft Excel (Microsoft, Redmond, WA, 
USA) and GraphPad Prism 5.0 (GraphPad software, San Diego, CA, USA). All results were 
reported as the mean +/- standard error of the mean (SEM) or standard deviation (SD) as 
indicated. Two-tailed paired and unpaired t-tests, and one-way ANOVA with Tukey post-tests 
were utilized for statistical analyses.  P-values less than 0.05 were considered significant. 
2.4 Results 
2.4.1 Malignant Neoplasms Express Heparan Sulfate Proteoglycans 
We are interested in exploiting differences in cell membrane electric phenotype to 
differentially capture cancer cells and blood cells under continuous flow conditions. Cancer cells 
express negatively charged heparan sulfate proteoglycans on their cell membranes; such 
proteoglycans are lacking on white blood cells (Figure 1a). The differential expression of 
proteoglycans results in differences in the electric charge of cells as measured by electrophoretic 
mobility, with cancer cells having higher negative electric charge than blood cells (Figure 1 b). 
Treating cells with heparanases to remove heparan sulfate proteoglycans diminishes the electric 
charge of cancer cells while that of white blood cells remains unchanged (Figure 1 b). Together 
these results demonstrate that cell surface proteoglycans contribute to differences in electric 
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charge between cancer cells and white blood cell types. Cancer cell expression of heparan sulfate 
proteoglycans results in these cells having elevated negative electric charge compared with white 
blood cells, which do not express heparan sulfate residues on their surfaces. 
Figure 1: Characterization of cancer cell and white blood cell electric phenotype. (A) To 
assess expression of negatively charged heparan sulfate proteoglycans on cell surfaces, 
fluorescent anti-heparan sulfate antibody was added to cancer cells and mononuclear 
leukocytes for 45 minutes.  Expression of fluorescent anti-heparan sulfate antibody on the 
surface of cancer cells and blood cells determined using flow cytometry. (B) Zeta potential 
measurements of cancer cells and white blood cells before and after treatment with 
heparanse III.  Values are mean ± standard deviation (n = 3).  
 
2.4.2 Cell Adhesion to Cationic Polymer Coated Microscale Flow Devices 
To test the adhesive potential of cells to cationic polymer-coated surfaces, three polymers 
at varied concentrations were individually adsorbed to the inner lumen of microscale flow 
devices and each device was used to measure the adhesive potential of malignant and non-
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malignant cells under flow (Figure 2A-B). Cells suspended in flow buffer containing 0.5% w/v 
serum albumin adhesively interacted with polymer-coated surfaces in a manner that depended on 
the concentration of cationic polymer adsorbed to the surfaces, with the greatest number of 
cancer and white blood cells firmly adhered on surfaces treated with 0.1% w/v cationic polymer 
(Figure 2 C – E). Surfaces coated with 0.025% w/v poly-L-lysine had the lowest number of 
white blood cells adhered while also showing elevated capture of the breast cancer cell line 
MDA-MB 231 (Figure 2 C). For this reason poly-L-lysine was chosen to study the effect fluid 
dielectric has on adhesive interactions between cells and charged surfaces. 
2.4.3 Serum Albumins Modulate Fluid Dielectric and Adhesive Interactions 
Between Cells and Poly-L-Lysine Coated Surfaces Under Flow 
 
Aqueous fluids have a high dielectric constant due to the polar nature of water molecules, 
which become ordered in the presence of electric fields [31]. Adding the protein human albumin 
to water increases the fluid’s electric permittivity and thus its dielectric constant (Figure 3 A). 
The increased fluid dielectric could in turn affect how electrical charges interact according to the 
force equations that describe those interactions (e.g., Coulomb’s law). To study the effect 
proteins have on cell adhesion to PLL-coated surfaces, we progressively suspended cells in 
buffers containing varying amounts of human serum albumin and flowed cells through PLL-
coated microscale flow devices. Blood cells suspended in a protein-free buffer adhesively 
interacted with poly-L-lysine under continuous flow in a manner that depended on the 
concentration of polymer adsorbed to the surface of microscale flow devices, suggesting that 
surfaces coated with higher concentrations of PLL contained higher electric charge density, 
allowing cells to form more adhesive electrostatic interactions (Figure 3 C). Interestingly, the 
addition of 0.5% w/v serum albumin to white cell buffer solution decreased white cell adhesion 
to surfaces coated with 0.025% poly-L-lysine, but white cell adhesion increased as the 
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concentration of poly-lysine adsorbed onto surfaces increased (Figure 3 C). Increasing albumin 
concentration further to 1% w/v nearly abrogated firm adhesion of white blood cells to PLL- 
coated surfaces while maintaining cancer cell adhesion at levels similar to those observed in 
protein-free and 0.5% albumin buffer solutions (Figure 3B), indicating that adding proteins to a 
buffer solution effectively modulates the potential of cells to adhere to charged surfaces 
according to their electric phenotype (Figure 3 B - C).  
Cancer cells expressing highly negative heparin sulfate proteoglycans showed increased 
electric charge compared with white blood cells (figure 1 B), and thus are able to form adhesive 
interactions with PLL-coated surfaces in higher dielectric media. Indeed, cleaving heparin sulfate 
proteoglycans from cancer cells reduced electric charge (Figure 1 C) and also reduced adhesion 
of these cells to PLL-coated surfaces (Supplementary figure 1). Polystyrene particles with 
electrical charge matched to that of cancer and blood cells used in this study were also observed 
to differentially interact with PLL-coated surfaces in protein-containing solutions 
(Supplementary figure 2). 
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Figure 2: Cell adhesion to cationic polymer coated surfaces under continuous flow. (A) 
Atomic structure of cationic polymers Poly-L-Lysine (PLL), Poly(allylamine) (PAA), and 
Poly(ethyleneimine) (PEI) used for capturing cells on treated surfaces. (B) Photograph of 
microscale flow devices mounted onto the stage of microscope and attached to motorized 
syringe pump. (C – E) Number of firmly adhered MDA-MB-231 breast cancer cells (black 
bars) and mononuclear leukocytes (white bars) per 180,000 um2 on surfaces coated with 
200 uL of 0.025 - 0.1% (w/v) cationic polymer.  Cancer cells (500,000 cells/mL) and white 
blood cells (1,000,000 cells/mL) were suspended in flow buffer containing 0.5% (w/v) 
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human serum albumin and flowed through devices at a flow rate of 0.008 mL/min (wall 
shear stress of 0.5 dyn/cm2) for 10 minutes. Surfaces were then washed another ten minutes 
with same flow buffer to obtain number of firmly adhered cells. (F – G) Images of 
leukocytes captured on surfaces functionalized with 0.025% w/v PLL (F) or 0.1% w/v PLL 
(G). (H – I) Images of MDA-MB-231 breast cancer cells captured on surfaces 
functionalized with 0.025% w/v PLL (H) or 0.1% w/v PLL (I). 
 
Figure 3: Human serum albumin modulates fluid dielectric and cellular adhesion to PLL-
coated surfaces under continuous flow. (A) Measured capacitance of air, water, and 
aqueous human serum albumin at concentration of 0.5 and 5% (w/v) albumin. Capacitance 
values were used to calculate the dielectric constant by dividing by capacitance of air. 
Calculated values are mean ± standard deviation (n = 3). (B - C) Number of firmly 
adhered MDA-MB-231 breast cancer cells and mononuclear leukocytes per 180,000 um2 on 
surfaces coated with 200 uL of 0.025 – 0.1% (w/v) PLL.  Cancer cells (500,000 cells/mL) 
and white blood cells (1,000,000 cells/mL) were suspended in PBS flow buffer containing 
0% (white bars), 0.5%(black bars), or 1%(striped bars) human serum albumin (HSA) and 
flowed through devices at a flow rate of 0.008 mL/min (wall shear stress of 0.5 dyn/cm2) for 
10 minutes.  Surfaces were then washed for ten minutes with same flow buffer used for 
each condition tested to remove un-adhered cells. n = 20 or more frames analyzed for 
captured cells for each condition.  Statistics were calculated using a one-way ANOVA with 
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Tukey post test. ***P < 0.0001, **P < 0.001, *P < 0.01, NS: not significant. (D – E) Images 
of MDA-MB-231 cancer cells captured on surfaces functionalized with 0.1% w/v PLL and 
cells suspended in PBS flow buffer supplemented with (D) 0%, (E) 0.5%, or (F) 1% w/v 
HSA.  (G – I) Images of leukocytes captured on surfaces functionalized with 0.1% w/v PLL 
and cells suspended in PBS flow buffer supplemented with (G) 0%, (H) 0.5%, or (I) 1% 
w/v HSA.   
 
 
Supplementary Figure 1: Heparanase treatment reduces adhesion of cancer cells to PLL 
coated surfaces under flow conditions. Heparanase III treated and untreated cells were 
perfused through microscale flow devices at flow rate 0.008 mL/min (wall shear stress 0.5 
dyn/cm2) for 10 minutes.  Unadhered cells were removed by perfusing flow buffer at the 
same rate for another ten minutes. n = 20 or more frames analyzed for captured cells for 
each condition.  Statistics were calculated using a two-tailed unpaired t-test. ***P < 0.0001. 
 
Altogether, these data show that negatively charged cell adhesion to cationic surfaces can 
be controlled by at least three variables: 1) the concentration of cationic polymer adsorbed on 
surfaces, which could correlate with the electric charge density of capture surfaces; 2) the 
electric charge of cell surfaces controlled by the expression of cell surface residues such as 
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heparan sulfate proteoglycans; and 3) the dielectric properties of the fluid modulated by the 
addition of albumin to the solution. These three variables can be tuned to affect cell adhesion to 
charged surfaces, providing scientists and clinicians with a new way of targeting rare cells of 
interest by controlling capture surface and fluid properties. 
 
Supplementary Figure 2: Negatively charged polystyrene particles differentially adhere to 
PLL coated surfaces in protein-containing buffer solution. 10 um sized polystyrene 
particles (0.025% w/v) possessing measured zeta potentials of -7 and -19 mV were 
suspended in PBS buffer with or without 0.5% (w/v) human serum albumin. -19 mV 
particles were produced by incubating -7 mV stock particles in 1% polystyrene sulfonate 
solution for 1 hour and washing particles 3 times to obtain functionalized negatively 
charged particles.  Particles were then flowed through PLL functionalized microscale flow 
devices containing 200 uL of 0.1% (w/v) PLL for 10 minutes at a flow rate of 0.008 mL/min 
(wall shear stress 0.5 dyn/cm2).  Unadhered particles were removed by perfusing flow 
buffer at the same rate for another ten minutes. n = 20 or more frames analyzed for 
captured cells for each condition.  Statistics were calculated using a two-tailed unpaired t-
test. ***P < 0.0001.  
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2.4.4 Isolation of CTCs from Blood of Metastatic Prostate Cancer Patients 
 
Approximately 1 CTC is present for every one million leukocytes in a given patient blood 
sample, and CTCs and leukocytes both adhesively interact with cationic surfaces (Fig. 2C – E). 
However, enhancing fluid dielectric with albumin nearly abrogated firm adhesion of leukocytes 
to charged surfaces (Fig. 3C). For this reason, blood taken from patients diagnosed with late-
stage prostate cancer was spun down to obtain a buffy coat layer, and subsequently suspended in 
buffer containing 1% HSA to minimize white cell fouling. The sample was then processed using 
microscale flow devices the inner lumen of which was functionalized with PLL to capture 
potential CTCs (Figure 4). Currently the state of the art for CTC detection utilizes monoclonal 
antibodies against transmembrane proteins such as epithelial cell adhesion molecules (EpCAM). 
Interestingly, some patients contained CTCs that were EpCAM+ and in the same blood sample 
CTCs that were EpCAM- (Figure 4B). 
2.5 Discussion 
An object in motion will continue in motion unless acted on by external force [32]. In our 
experiments we set cells in motion using a motorized syringe pump and observed changes in the 
state of the cells’ motion as they transitioned from continuous flow to firm adhesion on charged 
surfaces. A change in motion is called acceleration. Whenever an object accelerates there must 
be a cause of that acceleration, and that cause is called the force:  
F = ma 
In the above equation ‘F’ is the net force, ‘m’ is the mass, and ‘a’ is the acceleration of the 
object. We commonly invoke four fundamental forces to describe interactions between objects 
and materials. The most familiar force is gravitation, which is responsible for apples falling from 
trees as well as the orbits of planets around the sun. The second-most familiar force is 
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electromagnetism, which underlies most of the interactions in the modern technological age. 
Like gravity, the electric force follows an inverse square law, which means that the strength of 
the force varies inversely with the square of the distance between the interacting objects. With  
 
 
Figure 4: CTCs isolated from patient blood. Blood of patients with advanced prostate 
cancers was spun down to obtain buffy coat, suspended in 1% HSA and flowed through 
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PLL functionalized microscale flow devices.  Samples were flowed through device at flow 
rate 0.008 mL/min (wall shear stress 0.5 dyn/cm2). (A-B) Number of prostate cancer cells 
captured from flow. Following processing, captured cells were released from the microtube 
and plated onto 8 mm, #1.5 thickness coverslips, fixed and stained with the following: anti-
CD45, anti-EpCAM, anti-PSMA (J591), anti pan-cytokeratin, and DAPI. CTCs were 
confirmed on basis of DAPI, cytokeratin, and CD45 staining. Only confirmed CTCs were 
included in final enumeration. Scale bar = 5 um.  
 
electrically charged objects, the magnitude of the force is proportional to the product of the two 
charges, q1 and q2, divided by r
2, the square of the distance between them: 
F = 
𝑞1
𝜀
𝑞2
𝑟2
 
This is Coulomb’s law. The constant, 𝜀, is a property of the space between the charges and is 
related to the dielectric constant. In our experiments we observed negatively charged objects 
interacting adhesively with positively charged polymer-coated surfaces under flow conditions 
and, by tuning the fluid dielectric using serum albumin, we were able to modulate firm adhesion 
of cells based on the electric phenotype of those cells. We observed elevated electric charge in 
cancer cells expressing heparan sulfate proteoglycans and those cells persisted in binding to 
charged surfaces in high dielectric fluids. White blood cells, on the other hand, firmly adhered to 
cationic surfaces but the number of firmly adhered cells decreased as the fluid dielectric 
increased until, eventually, at 1% protein concentration, we observed almost no white blood cell 
adhesion. The combination of both fluid dielectric and surface charge can increase both the 
number and purity of CTCs isolated from patient blood, which can enable the development of 
effective personalized cancer therapies. 
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